Colinz Laboratories (BOM:531210) 5-Year EBITDA Growth Rate : 31.80% (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Colinz Laboratories 5-Year EBITDA Growth Rate?

Colinz Laboratories's EBITDA per Share for the three months ended in Mar. 2024 was ₹0.92.

During the past 12 months, Colinz Laboratories's average EBITDA Per Share Growth Rate was 4.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 41.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 31.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Colinz Laboratories was 48.10% per year. The lowest was -6.60% per year. And the median was 1.20% per year.

Competitive Comparison of Colinz Laboratories's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Colinz Laboratories's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Colinz Laboratories's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Colinz Laboratories's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Colinz Laboratories's 5-Year EBITDA Growth Rate falls into.

Colinz Laboratories 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Colinz Laboratories (BOM:531210) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Colinz Laboratories 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Colinz Laboratories's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Colinz Laboratories (BOM:531210) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Colinz Laboratories Ltd (BOM:531210) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Mulund Goregaon Link Road, A-101 Pratik Industrial Estate, Next to Fortis Hospital, Bhandup (West), Mumbai, MH, IND, 400078

Website

http://www.colinz.com

Colinz Laboratories Ltd is an India based company engaged in manufacturing of pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathy, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.

Colinz Laboratories (BOM:531210) Headlines

No Headlines